News & Blog
University of Maryland Center of Excellence in Regulatory Science (M-CERSI) and Innovation Conference on Patient-Focused Drug Development
March 19, 2015 | News Updates
On March 9, the M-CERSI Conference on Patient-Focused Drug Development, was held in Bethesda, MD. The conference included planning members M-CERSI, Food and Drug Administration, academia, and industry, and was open to patients, caregivers, and advocacy groups. It provided a forum for all patient-focused drug development (PFDD) stakeholders to gather for an open dialogue.
Topics covered included:
- Definition of PFDD
- Essential components that need to be included in successful PFDD
- Current initiatives, such as those of the FDA, patient advocacy groups, and pharmaceutical companies
- Challenges to achieving PFDD and methods to overcome those challenges
- Recommendations on a plan of action that includes a description of stakeholders’ roles to move PFDD forward
Individual presenters’ slides can be viewed here.